Analysis originally distributed on March 7, 2018 By: Michael Vodicka of Cannabis Stock Trades
The Canadian cannabis sector scored another blockbuster win last week - and it led to a quick 30% gain for one of Canada's most promising young cannabis companies. If you missed the recent pop higher don't worry - I see this same pattern repeating itself at least a few more times in the next three months. Here's what is going on.
Cronos Group (CRON) is one of Canada's largest and most promising cannabis companies. Shares began trading on the Toronto Venture Stock Exchange in December of 2014. Since then, Cronos has delivered huge gains to shareholders, jumping more than 1400% from its IPO price of $.80.
That impressive performance helped Cronos make history last week when it became the first ever Canadian cannabis producer to trade on the US-based NASDAQ stock exchange. Continue reading "My Plan For Another 30% Gain In 5 Days"
Analysis originally distributed on January 3, 2018 By: Michael Vodicka of Cannabis Stock Trades
2017 turned out to be a great year for cannabis stocks - particularly if you knew which stocks to buy.
The North American Cannabis Index was up 86% in 2017.
Canadian stocks were on fire - the Canadian Cannabis Index was up 160% in 2017.
Most improved award goes to US cannabis stocks - they were steadily falling for most of the year - down 40% on the year in late October.
Then in early November, a major rally kicked in and US cannabis stocks rallied hard - with the US cannabis index jumping more than 100% from the 52-week low. Continue reading "North American Cannabis Index Jumps 86% in 2017"
Analysis originally distributed on May 19, 2017 By: Michael Vodicka of Cannabis Stock Trades
First-quarter earnings season is almost over.
And the cannabis sector has been knocking it out of the park.
A lot of the stocks that we have covered over the last few months have stepped up and delivered excellent results.
Let's take a closer look.
In terms of pure growth, the best report I've seen came from Aurora Cannabis (ACBFF), one of the largest medical cannabis companies in Canada
Revenue jumped 2,500% from the same period last year to $5.2 million and was up 33% from just last quarter. Continue reading "Aurora Delivers 2,500% Revenue Growth in 12 Months"